Company Bright Green Corporation

BGXX

US10920G1004

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

End-of-day quote Nasdaq Other stock markets 06:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
0.2106 ^USD	-1.73%		-1.73%	-36.20%

May. 20	Bright Green Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 16	Bright Green Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Bright Green Corporation is a producer and manufacturer of plant-based drugs and active pharmaceutical ingredients (APIs). The Company specializes in the research, production, distribution, and advancement of plant-based drugs and APIs, including psilocybin, psilocyn, peyote, and opium poppy. It plans to focus on the development of cannabis strains and sales of cannabis and hemp products with high contents of cannabinol (CBN) and cannabigerol (CBG). It also plans to cultivate cannabis and focus on the production of dried flowers, and oils and marijuana extracts. In addition to cannabis, it also has a separate area for controlled substance cactus cultivation, and a separate controlled area for mushroom propagation. It is in the process of completing construction of the 22-acre existing greenhouse to comply with the requirements for Schedule I and Schedule II plant-based drugs. It also plans to construct two new 57-acre greenhouses, one each on the Candelaria property and Azuz property.

Number of employees: 5

Managers	Title	Age	Since
Saleem Elmasri DFI	Director of Finance/CFO	39	22-02-28
Gurvinder Singh		47	-

Members of the board	Title	Age	Since
Lynn Stockwell FOU	Founder	66	19-04-15
Dean M. Vallore BRD	Director/Board Member	51	19-12-31
Robert Arnone BRD	Director/Board Member	57	21-06-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	190,166,318	64,934,700 ( 34.15 %)	0	34.15 %

Name	Equities	%	Valuation
Lynn Stockwell 36.38 %	69,183,658	36.38 %	13 M $
Terry Rafih 11.79 %	22,425,000	11.79 %	4 M $
Ernie Mailloux 11.15 %	21,200,000	11.15 %	4 M $
BlackRock Advisors LLC 1.816 %	3,453,910	1.816 %	635 519 $
Vanguard Fiduciary Trust Co. 1.489 %	2,831,636	1.489 %	521 021 $
Geode Capital Management LLC 0.7690 %	1,462,339	0.7690 %	269 070 $
ETF Managers Group LLC 0.7302 %	1,388,675	0.7302 %	255 516 $
STATE STREET CORPORATION 0.5273 %	1,002,748	0.5273 %	184 506 $
Saleem Elmasri 0.5259 %	1,000,000	0.5259 %	184 000 $
Northern Trust Investments, Inc.(Investment Management) 0.2743 %	521,579	0.2743 %	95 971 $

Bright Green Corp.

1033 George Hanosh Boulevard

87020, Grants

http://www.brightgreen.us

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
BRIGHT GREEN CORPORATION	-36.20%	41.93M
ELI LILLY AND COMPANY	+37.78%	723B
NOVO NORDISK A/S	+30.20%	598B
JOHNSON & JOHNSON	-3.51%	364B
MERCK & CO., INC.	+19.94%	331B
ABBVIE INC.	+5.14%	288B
ASTRAZENECA PLC	+16.04%	244B
ROCHE HOLDING AG	-5.03%	208B
NOVARTIS AG	+9.83%	210B
AMGEN INC.	+9.32%	169B

Other Pharmaceuticals